Reuters logo
BRIEF-Loxo Oncology announces collaboration with Ventana Medical Systems
March 20, 2017 / 10:59 AM / 6 months ago

BRIEF-Loxo Oncology announces collaboration with Ventana Medical Systems

March 20 (Reuters) - Loxo Oncology Inc

* Loxo Oncology announces larotrectinib pan-trk ihc companion diagnostic collaboration with Ventana Medical Systems, Inc., a member of the Roche Group

* Agreement to develop and commercialize a pan-trk immunohistochemistry (ihc) test

* IHC test is a companion diagnostic to identify patients across tumor types suitable for treatment with larotrectinib

* Loxo Oncology - Roche is responsible for developing, obtaining, maintaining regulatory approvals for companion diagnostic test in u.s., specific countries in eu Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below